Research field (4):
Cell biology
, Molecular biology
, Physiology
, Immunology
Research keywords (5):
drug discovery
, inflammation
, pruritus
, Allergy
, Atopic dermatitis
Research theme for competitive and other funds (4):
2022 - 2025 Development of novel molecular-targeting drugs for atopic dermatitis applying macrocyclic peptides
2022 - 2025 Mechanistic Investigation of atopic dermatitis associated with abnormality in endocrine and metabolic systems
2020 - 2022 Dysregulation of metabolic and endocrine systems that triggers the onset of atopic dermatitis
2018 - 2020 Elucidation of mechanism for triggering an onset of atopic dermatitis
Papers (15):
Ryo Hirase, Tomoyuki Fujita, Tomohiro Miyai, Hiroshi Kawasaki, Haruhiko Koseki. Pharmacological Impacts of Mucopolysacccharide Polysulfates in the Epidermis Involves Inhibition of Amphiregulin-Mediated Signals in Keratinocytes. Experimental Dermatology. 2024. 33. 10
Jonathan Moody, Tsukasa Kouno, Miki Kojima, Ikuko Koya, Julio Leon, Akari Suzuki, Akira Hasegawa, Taishin Akiyama, Nobuko Akiyama, Masayuki Amagai, et al. A single-cell atlas of transcribedcis-regulatory elements in the human genome. bioRxiv. 2023
T. Miyai, H. Kawasaki, H. Matsunaga, M. Hosokawa, A. Sekita, H. Takeyama, M. Amagai, H. Koseki. 162 Application of microdissection-based spatial transcriptomics for mechanistic and biomarker investigations in dermatology. Journal of Investigative Dermatology. 2021. 141. 5. S29-S29
T Miyai, H Kawasaki, M Hosokawa, H Matsunaga, R Satoh, A Sekita, H Takeyama, M Amagai, H Koseki. Micro-regional transcriptome reveals local dermal-epidermal intercorrelation in atopic dermatitis. Journal of Investigative Dermatology. 2020. 140. 7. S109
Tomohiro Miyai, Tomokatsu Ikawa. Stepwise transcriptional regulation that drives the commitment of multipotent progenitors into B cells. Clinical Immunology & Allergology. 2018. 70. 5. 503-513
Application of microdissection-based spatial transcriptomics for mechanistic and biomarker investigations in dermatology
(2021 SID Virtual Meeting 2021)
FGF23 is a novel endocrine regulator for the pathogenesis of atopic dermatitis
(The 48th Annual Meeting of The Japanese Society for Immunology 2019)
Transcriptional network for proper fate devision into B cell lineage.
(The 44th Annual Conference of Japanese Society of Immunology 2015)
2011 - 2016 Osaka University Graduate School of Frontier Bioscience
2007 - 2011 Hiroshima University School of Applied Biological Science
Professional career (1):
博士(理学) (大阪大学)
Work history (8):
2021/04 - 現在 RIKEN IMS Laboratory for Developmental Genetics Research Scientist
2020/01 - 現在 Keio University School of Medicine Department of Dermatology Collaborative Researcher
2019/03 - 現在 RIKEN Program for Drug Discovery and Medical Technology Platforms Theme Leader for Development of Atopic Dermatitis Therapeutic Agents
2020/04 - 2021/03 RIKEN Lab for Developmental Genetics, Center for Integrative Medical Sciences / Immunology Data Integration Unit, Medical Sciences Innovation Hub Program Postdoctoral Researcher
2017/08 - 2020/03 RIKEN Lab for Developmental Genetics (Center for Integrative Medical Sciences) / Disease Biology Group (Medical Sciences Innovation Hub Program) Postdoctoral Researcher